Fund Holdings — TYBOURNE CAPITAL MANAGEMENT (HK) LTD

Total Portfolio Value:
$34.54M
Total Bought:
$18.16M
Total Sold:
$7.18M
Net Transaction:
+$10.98M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Forte Biosciences Inc (Fbrx Us)619,981786,647+166,666$4.81M$10.17M29.45%+$5.36M
Taysha Gene Therapies, Inc.(TSHA)3,700,0004,095,000+395,000$5.14M$9.46M27.39%+$4.32M
Bicycle Therapeutics Ltd-Adr (Bcyc Us)ADS576,343993,743+417,400$4.89M$6.91M20.00%+$2.01M
Alumis Inc (Alms Us)01,399,250+1,399,250$0$4.20M12.15%+$4.20M
Malibu Boats, Inc.CL A(MBUU)066,705+66,705$0$2.09M6.05%+$2.09M
Zentalis Pharmaceuticals, Inc.(ZNTL)961,4861,478,152+516,666$1.53M$1.71M4.96%+$185.9K
Acelyrin Inc (Slrn Us)2,906,6290-2,906,629$7.18M$0—-$7.18M
Page 1 of 1
TYBOURNE CAPITAL MANAGEMENT (HK) LTD — 13F Holdings — Q2 2025 | TickerTrail